US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Alcon Inc. Ordinary Shares (NY:ALC)

63.76 -0.18 (-0.28%)
Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Mid-Day Market Update: Alcon Rises Following Q2 Results; NexPoint Real Estate Finance Shares Slide ↗
Midway through trading Wednesday, the Dow traded down 0.12% to 35,299.82 while the NASDAQ fell 0.01% to 14,654.93. The S&P also fell, dropping 0.10% to 4,443.63. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
34 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday. Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 58% to $... 
Via Benzinga
News headline image
22 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares rose 50.6% to $23.12 in pre-market trading. Virpax Pharmaceuticals shares jumped 265% on Tuesday after the company... 
Via Benzinga
News headline image
A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Fed Minutes ↗
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade ahead of the release of minutes from the Fed meeting. Investors are awaiting earnings results from... 
Via Benzinga
Topics Economy
News headline image
Investors Cheer Alcon's Updated Annual Guidance ↗
Alcon AG (NYSE: ALC) reported second-quarter FY21 sales of $2.1 billion, +75% Y/Y on a reported basis and +69% on a constant currency basis, beating the consensus of $1... 
Via Benzinga
News headline image
Alcon Reports Second Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
News headline image
Earnings Scheduled For August 17, 2021 ↗
Companies Reporting Before The Bell • AiHuiShou Intl (NYSE:RERE) is expected to report earnings for its second quarter. • Ozon Holdings (NASDAQ:OZON) is expected... 
Via Benzinga
News headline image
Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Announces Executive Committee Changes
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Inc (ALC) Q1 2021 Earnings Call Transcript ↗
ALC earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Alcon's Q1 Sales Boosted By Equipment, Implantables In Surgical Segment, FY21 Outlook In-Line With Expectations ↗
Alcon AG (NYSE: ALC) reported first-quarter FY21 sales of $1.9 billion, an increase of 5% Y/Y on a reported basis and 2% on a constant currency basis,... 
Via Benzinga
News headline image
Alcon Reports First Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
News headline image
Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.
From Alcon Inc. Investors
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >